Pfizer
Sunitinib-sutent
“Sunitinib” is the Drug / Molecule content in "Sutent". Sunitinib inhibits cellular signaling by targeting multiple receptor tyrosine kinases (RTKs).These include all recepta for platelet-derived growt factor receptars (PDGF-Rs) and vascular endothelial growt factor receptars (VEGFRs), which play a role in both tumor angiogenesis and tumor cell proliferation. The simultaneous inhibition of these targets therefore leads to both reduced tumor vascularization and cancer cell death, and ultimately tumor shrinkage.
Indication
Sutent is indicated for the treatment of Gastrointestinal Stromal Tumor after disease progression on or intolerance to Imatinib Mesylate. It is also indicated for the treatment of Advance Renal Cell Carcinoma.
Note
Precaution
- Sutent is a prescription drug and should be used under proper medical guidance and advice.
- Sutent can cause serious liver problems, including death.
Strength
12.5 mg, 25 mg, 50 mg
Packing
1 X 7 Capcules (Strip)
Storage
Store in a cool place, protect from light.
Was this page helpful?
Most Viewed Products
Abiraterone acetate-xbira
Bendamustine-bendit
Bicalutamide-cassotide
Bortezomib-bortenat
Erlonat
Everolimus-evertor
Exemestane-xtane
Geftinat
Glatiramer acetate-glatimer
Ledipasvir & sofosbuvir-hepcinat lp
Lenalidomide-lenalid
Pomalidomide-pomalid
Sofosbuvir & velpatasvir-velpanat
Sorafenib-sorafenat
